NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Michael B. Streiff; Bjorn Holmstrom; Dana Angelini; Aneel Ashrani; Paula L. Bockenstedt; Carolyn Chesney; John Fanikos; Randolph B. Fenninger; Annemarie E. Fogerty; Shuwei Gao; Samuel Z. Goldhaber; Krishna Gundabolu; Paul Hendrie; Alfred I. Lee; Jason T. Lee; Janelle Mann; Brandon McMahon; Michael M. Millenson; Colleen Morton; Thomas L. Ortel; Sadat Ozair; Rita Paschal; Sanford Shattil; Tanya Siddiqi; Kristi J. Smock; Gerald Soff; Tzu Fei Wang; Eliot Williams; Anaadriana Zakarija; Lydia Hammond; Mary A. Dwyer; Anita M. Engh

doi:10.6004/jnccn.2018.0084

NCCN Guidelines^® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Michael B. Streiff, Bjorn Holmstrom, Dana Angelini, Aneel Ashrani, Paula L. Bockenstedt, Carolyn Chesney, John Fanikos, Randolph B. Fenninger, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Krishna Gundabolu, Paul Hendrie, Alfred I. Lee, Jason T. Lee, Janelle Mann, Brandon McMahon, Michael M. Millenson, Colleen Morton, Thomas L. OrtelSadat Ozair, Rita Paschal, Sanford Shattil, Tanya Siddiqi, Kristi J. Smock, Gerald Soff, Tzu Fei Wang, Eliot Williams, Anaadriana Zakarija, Lydia Hammond, Mary A. Dwyer, Anita M. Engh

Research output: Contribution to journal › Article › peer-review

184 Scopus citations

Abstract

Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

Original language	English (US)
Pages (from-to)	1289-1303
Number of pages	15
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	16
Issue number	11
DOIs	https://doi.org/10.6004/jnccn.2018.0084
State	Published - Nov 1 2018

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2018.0084

Cite this

Streiff, M. B., Holmstrom, B., Angelini, D., Ashrani, A., Bockenstedt, P. L., Chesney, C., Fanikos, J., Fenninger, R. B., Fogerty, A. E., Gao, S., Goldhaber, S. Z., Gundabolu, K., Hendrie, P., Lee, A. I., Lee, J. T., Mann, J., McMahon, B., Millenson, M. M., Morton, C., ... Engh, A. M. (2018). NCCN Guidelines^® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(11), 1289-1303. https://doi.org/10.6004/jnccn.2018.0084

Streiff, MB, Holmstrom, B, Angelini, D, Ashrani, A, Bockenstedt, PL, Chesney, C, Fanikos, J, Fenninger, RB, Fogerty, AE, Gao, S, Goldhaber, SZ, Gundabolu, K, Hendrie, P, Lee, AI, Lee, JT, Mann, J, McMahon, B, Millenson, MM, Morton, C, Ortel, TL, Ozair, S, Paschal, R, Shattil, S, Siddiqi, T, Smock, KJ, Soff, G, Wang, TF, Williams, E, Zakarija, A, Hammond, L, Dwyer, MA & Engh, AM 2018, 'NCCN Guidelines^® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 11, pp. 1289-1303. https://doi.org/10.6004/jnccn.2018.0084

@article{a5175fcd0bed466cb5e301c40950dbb6,

title = "NCCN Guidelines{\textregistered} insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines",

abstract = "Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.",

author = "Streiff, {Michael B.} and Bjorn Holmstrom and Dana Angelini and Aneel Ashrani and Bockenstedt, {Paula L.} and Carolyn Chesney and John Fanikos and Fenninger, {Randolph B.} and Fogerty, {Annemarie E.} and Shuwei Gao and Goldhaber, {Samuel Z.} and Krishna Gundabolu and Paul Hendrie and Lee, {Alfred I.} and Lee, {Jason T.} and Janelle Mann and Brandon McMahon and Millenson, {Michael M.} and Colleen Morton and Ortel, {Thomas L.} and Sadat Ozair and Rita Paschal and Sanford Shattil and Tanya Siddiqi and Smock, {Kristi J.} and Gerald Soff and Wang, {Tzu Fei} and Eliot Williams and Anaadriana Zakarija and Lydia Hammond and Dwyer, {Mary A.} and Engh, {Anita M.}",

note = "Publisher Copyright: {\textcopyright} National Comprehensive Cancer Network, Inc.",

year = "2018",

month = nov,

day = "1",

doi = "10.6004/jnccn.2018.0084",

language = "English (US)",

volume = "16",

pages = "1289--1303",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Harborside Press",

number = "11",

}

TY - JOUR

T1 - NCCN Guidelines® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

AU - Streiff, Michael B.

AU - Holmstrom, Bjorn

AU - Angelini, Dana

AU - Ashrani, Aneel

AU - Bockenstedt, Paula L.

AU - Chesney, Carolyn

AU - Fanikos, John

AU - Fenninger, Randolph B.

AU - Fogerty, Annemarie E.

AU - Gao, Shuwei

AU - Goldhaber, Samuel Z.

AU - Gundabolu, Krishna

AU - Hendrie, Paul

AU - Lee, Alfred I.

AU - Lee, Jason T.

AU - Mann, Janelle

AU - McMahon, Brandon

AU - Millenson, Michael M.

AU - Morton, Colleen

AU - Ortel, Thomas L.

AU - Ozair, Sadat

AU - Paschal, Rita

AU - Shattil, Sanford

AU - Siddiqi, Tanya

AU - Smock, Kristi J.

AU - Soff, Gerald

AU - Wang, Tzu Fei

AU - Williams, Eliot

AU - Zakarija, Anaadriana

AU - Hammond, Lydia

AU - Dwyer, Mary A.

AU - Engh, Anita M.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

AB - Venous thromboembolism (VTE) is common in patients with cancer and increases morbidity and mortality. VTE prevention and treatment are more complex in patients with cancer. The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease outline strategies for treatment and prevention of VTE in adult patients diagnosed with cancer or in whom cancer is clinically suspected. These NCCN Guidelines Insights explain recent changes in anticoagulants recommended for the treatment of cancer-associated VTE.

UR - http://www.scopus.com/inward/record.url?scp=85056665720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056665720&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0084

DO - 10.6004/jnccn.2018.0084

M3 - Article

C2 - 30442731

AN - SCOPUS:85056665720

SN - 1540-1405

VL - 16

SP - 1289

EP - 1303

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 11

ER -

NCCN Guidelines^® insights cancer-associated venous thromboembolic disease, version 2.2018 featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this